Vempati, R.; Damarlapally, N.; Roy, P.; Mylavarapu, M.; Vasudevan, S.S.; Reguram, R.; Vora, T.; Jain, H.; Ahmed, R.; Krishnamoorthy, G.
Metformin and Risk of New-Onset Atrial Fibrillation in Type 2 Diabetes: A Systematic Review and Meta-Analysis. Diagnostics 2025, 15, 2288.
https://doi.org/10.3390/diagnostics15182288
AMA Style
Vempati R, Damarlapally N, Roy P, Mylavarapu M, Vasudevan SS, Reguram R, Vora T, Jain H, Ahmed R, Krishnamoorthy G.
Metformin and Risk of New-Onset Atrial Fibrillation in Type 2 Diabetes: A Systematic Review and Meta-Analysis. Diagnostics. 2025; 15(18):2288.
https://doi.org/10.3390/diagnostics15182288
Chicago/Turabian Style
Vempati, Roopeessh, Nanush Damarlapally, Poulami Roy, Maneeth Mylavarapu, Srivatsa Surya Vasudevan, Reshma Reguram, Tanisha Vora, Hritvik Jain, Raheel Ahmed, and Geetha Krishnamoorthy.
2025. "Metformin and Risk of New-Onset Atrial Fibrillation in Type 2 Diabetes: A Systematic Review and Meta-Analysis" Diagnostics 15, no. 18: 2288.
https://doi.org/10.3390/diagnostics15182288
APA Style
Vempati, R., Damarlapally, N., Roy, P., Mylavarapu, M., Vasudevan, S. S., Reguram, R., Vora, T., Jain, H., Ahmed, R., & Krishnamoorthy, G.
(2025). Metformin and Risk of New-Onset Atrial Fibrillation in Type 2 Diabetes: A Systematic Review and Meta-Analysis. Diagnostics, 15(18), 2288.
https://doi.org/10.3390/diagnostics15182288